Thi Tra Bui, Hee-Yeon Kang, Eunjung Park, Jin-Kyoung Oh
{"title":"Latency period of lung cancer in relation to tobacco smoking in Korea.","authors":"Thi Tra Bui, Hee-Yeon Kang, Eunjung Park, Jin-Kyoung Oh","doi":"10.4178/epih.e2026014","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This mixed-methods observational study aimed to examine the temporal relationship between trends in cigarette smoking prevalence and lung cancer mortality and incidence rates, and to estimate the latency period between smoking initiation and lung cancer diagnosis among smokers at the individual level.</p><p><strong>Methods: </strong>Smoking prevalence data for 1960-2022 were reconstructed using data from the Korea National Health and Nutrition Examination Survey (1998-2022). Lung cancer mortality data (1983-2022) and incidence data (1999-2022) were obtained from Statistics Korea and the Korea Central Cancer Registry. The population latency period was estimated using peak comparison and distributed lag non-linear models. The individual latency period was estimated as the average time interval between age at smoking initiation and age at lung cancer diagnosis using individual-level data from the National Health Insurance Service cohort.</p><p><strong>Results: </strong>In men, smoking prevalence peaked around 1985, whereas lung cancer mortality peaked around 2000 during 1960-2022, indicating a lag time of approximately 15 years. In women, lung cancer mortality peaked in 2002, while smoking prevalence peaked around the same time. The population-level latency period between smoking and lung cancer incidence was estimated to be 15 years after adjustment for age, gender, and year of outcome. The individual latency period was estimated to be 42.6 years (standard deviation [SD], 12.5) in men and 34.4 years (SD, 14.2) in women. Smoking intensity and age at initiation did not appear to shorten the individual latency period.</p><p><strong>Conclusions: </strong>Estimates of the smoking-attributable lung cancer burden should account for historical smoking prevalence from approximately 15 years earlier.</p>","PeriodicalId":48543,"journal":{"name":"Epidemiology and Health","volume":" ","pages":"e2026014"},"PeriodicalIF":2.4000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13219974/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology and Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4178/epih.e2026014","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This mixed-methods observational study aimed to examine the temporal relationship between trends in cigarette smoking prevalence and lung cancer mortality and incidence rates, and to estimate the latency period between smoking initiation and lung cancer diagnosis among smokers at the individual level.
Methods: Smoking prevalence data for 1960-2022 were reconstructed using data from the Korea National Health and Nutrition Examination Survey (1998-2022). Lung cancer mortality data (1983-2022) and incidence data (1999-2022) were obtained from Statistics Korea and the Korea Central Cancer Registry. The population latency period was estimated using peak comparison and distributed lag non-linear models. The individual latency period was estimated as the average time interval between age at smoking initiation and age at lung cancer diagnosis using individual-level data from the National Health Insurance Service cohort.
Results: In men, smoking prevalence peaked around 1985, whereas lung cancer mortality peaked around 2000 during 1960-2022, indicating a lag time of approximately 15 years. In women, lung cancer mortality peaked in 2002, while smoking prevalence peaked around the same time. The population-level latency period between smoking and lung cancer incidence was estimated to be 15 years after adjustment for age, gender, and year of outcome. The individual latency period was estimated to be 42.6 years (standard deviation [SD], 12.5) in men and 34.4 years (SD, 14.2) in women. Smoking intensity and age at initiation did not appear to shorten the individual latency period.
Conclusions: Estimates of the smoking-attributable lung cancer burden should account for historical smoking prevalence from approximately 15 years earlier.
目的:本观察性研究旨在探讨吸烟流行趋势与肺癌死亡率和发病率之间的时间关系,并在个体水平上估计吸烟者开始吸烟和肺癌诊断之间的潜伏期。方法:利用1998-2022年韩国国家健康与营养检查调查(Korea National Health and Nutrition Examination Survey)的数据重建1960-2022年的吸烟率数据。肺癌死亡率数据(1983-2022年)和发病率数据(1999-2022年)来自韩国中央癌症登记处。利用峰值比较和分布滞后非线性模型估计种群潜伏期。个体潜伏期估计为开始吸烟年龄和肺癌诊断年龄之间的平均时间间隔,使用来自国家健康保险服务队列的个人水平数据。结果:在男性中,吸烟率在1985年左右达到顶峰,而肺癌死亡率在1960-2022年期间在2000年左右达到顶峰,表明滞后时间约为15年。在女性中,肺癌死亡率在2002年达到顶峰,而吸烟率也在同一时间达到顶峰。在调整年龄、性别和结果年份后,吸烟和肺癌发病率之间的人群水平潜伏期估计为15年。男性个体潜伏期估计为42.6年(标准差[SD], 12.5),女性为34.4年(标准差[SD], 14.2)。吸烟强度和起始年龄并没有缩短个体潜伏期。结论:对吸烟导致的肺癌负担的估计应该考虑到大约15年前的历史吸烟率。
期刊介绍:
Epidemiology and Health (epiH) is an electronic journal publishing papers in all areas of epidemiology and public health. It is indexed on PubMed Central and the scope is wide-ranging: including descriptive, analytical and molecular epidemiology; primary preventive measures; screening approaches and secondary prevention; clinical epidemiology; and all aspects of communicable and non-communicable diseases prevention. The epiH publishes original research, and also welcomes review articles and meta-analyses, cohort profiles and data profiles, epidemic and case investigations, descriptions and applications of new methods, and discussions of research theory or public health policy. We give special consideration to papers from developing countries.